HCV Care Pathway in Ile-de-France

Hepatitis C Virus Clinical Trial

— ParcoursVHC  

Official title:

HCV Care Pathway in Ile-de-France

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT02893046
• Other study ID #: RARS 28
• Status: Not yet recruiting
• Phase: N/A
• First received: August 25, 2016
• Last updated: September 1, 2016
• Start date: September 2016
• Est. completion date: September 2019

Study information

• Verified date: August 2016
• Source: Assistance Publique - Hôpitaux de Paris
• Contact: Stéphanie DOMINGUEZ, MD
• Phone: (0)1 49 81 25 26
• Email: stephanie.dominguez[@]aphp.fr
• Is FDA regulated: No
• Health authority: France: Ministry of Health
• Study type: Observational

Clinical Trial Summary

The main objective of this research is to evaluate a care pathway adapted to different category populations at risk of being infected with the hepatitis C virus in order to improve both the diagnosis turnaround times and the access to treatment. The aim is to allow a quick and effective access to diagnosis and treatment of HCV by strengthening the city hospital networks, access to early consultations and coordination of medical social actors.

Description:

The current estimation of infected persons with chronic hepatitis C in France is over 200 ,000. It appears that prevention, screening, care management, medical and social care of patients can be significantly improved especially among the most vulnerable populations. Indeed, these new HCV infections are mediated by drug-using people, prisoners, migrants, men who have sex with men (MSM) and who are supported too late and without real access to treatment.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 1000
• Est. completion date: September 2019
• Est. primary completion date: September 2017
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• 18 years old and more

• Positive Hepatitis C virus

• Patient having expressed a non-objection to participate in this research

Exclusion Criteria: None

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Hepatitis C
• Hepatitis C Virus

Intervention

Other:
• No intervention

Locations

Country	Name	City	State
France	Henri Mondor Hospital	Creteil

Sponsors (2)

Lead Sponsor	Collaborator
Assistance Publique - Hôpitaux de Paris	Agence Regionale de Sante Ile de France

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of patients effectively cared divided by number of patients eligible to care.		Year 3	No
Secondary	Number of patients cared in the HCV care pathway in Ile-de-France		Year 3	No
Secondary	Number of patients effectively treated divided by number of patients eligible to DAA treatment.		Year 3	No
Secondary	Delay between HCV diagnosis and early consultation		Year 3	No